Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
1 in 4
Topics
Alopecia
Psoriasis
VitiligoHidradenitis Suppurativa
Atopic Dermatitis
Hair Loss
Alopecia
Hair cycle
Anagen
• Growth phase
• Can last 2-6 years
• 80-90%
Catagen
• Regression and Apoptosis
• Some hair loss is early entry into this phase
• Last 2 weeks
• 1%
Telogen
• Resting phase
• Last 10 days
• 1-15%
Androgenetic
Alopecia
Trichotillomania
Self inflicted hair loss
Telogen Effluvium
Chronic Inflammation
Common thread in all types
• Including Androgenic Alopecia
• Micro-inflammation
1
Present at the follicle
2
Anagen
• Initiated by Dermal Papilla Cells (DPC)
• Secrete mediators which regulate stem cells
• Influence growth
• Anagen Stimulating Factors
• IGF-1
• bFGF
• VEGF
Catagen
• Decrease in anagen-maintaining factors
• Increase in Pro-apoptotic cytokines
• TGF-b
• IL-1
• TNF-a
Stem Cells and Immune Privilege
Each follicle has a stem cell reservoir
01Immune Privilege
• One of few sites in the body
• Prevents the induction of both innate and adaptive immune responses
02
Receptors – balance of ALL determines
growth Retinoids
Micro-Inflammation
• Leads to overproduction of IL-1, TNF-a
• TGF-b is over produced
• Signals growth arrest
• ROS
• UV light, pollutants, stress, aging, smoking, bacteria, fungi, etc
• Psycho-emotional stress
• Occurs over time
• Interferes with normal cycling and stem cell renewal
• Induces Catagen
Thyroid Disease
Atopic Disease
Metabolic Syndrome
H. Pylori Infection
Lupus Erythematous
Iron Deficiency
Anemia
Vitamin D Deficiency
Psychiatric Diseases
Autoimmune disorders
Treatment
IL steroid injections (2.5 – 5mg/cc)
Topical Class 1 Steroids (Clobetasol) foams
Biotin 2500-3000 mcg daily
Rogaine 5% foam
Others…
Ketoconazole shampoo
Zyrtec
MVI, Vit D3
Elidel
On the
horizon
• JAK inhibitors
• Oral meds
• PF-06651600 (a JAK3 inhibitor) and PF-06700841
(a JAK1/tyrosine kinase 2 inhibitor)
• Inhibit enzymes (Janus Kinase) which are activated
by cytokines leading to the blocking of pro-
inflammatory gene transcription.
• Block several ILs at once
• Assessment: SALT score
• Involved scalp surface area (SSA)
Potential side effects of JAK
Known from Xelganz
(tofactinib)
TB and Hepatitis screening required
Cancer Elevated lipids
Kidney and liver dysfunction
Anemia*Feb. 2019 - PE
and death
Vitiligo
Vitiligo
• “Autoimmune disorder”
• Absence of functional or recognizable melanocytes
• Inflammatory process
• High levels of TNFa, IL-1 and 17
• Vitamin deficiency??
• Maybe – an over reactive response to protect against MM
Cause ~ not completely understood
0.5-2% of population
• Not statistical – more females present
More females than males?
Average age of onset: 20 years old
1873 Medical records reviewed
20% had at least one comorbid diagnosis
Alopecia areata Addison disease
Autoimmune gastritis IBD
Pernicious anemia Psoriasis
RA Systemic lupus
31 fold increase in frequency of alopecia areata than general population
Also found association with: Guillain-Barre, myasthenia gravis, linear morphea, discoid
lupus and Sjogren syndrome
Treatments??
• Depigmentation with hydroquinone 20% -
Monobenzone – only FDA approved
• TCS
• Tacrolimus 0.3-1% ointment
• Vitamin supplements? (C, Folic Acid, B12)
• Surgical: punch minigrafting
• Melgain??
• Laser – Xtrac
• JAK Inhibitors
Psoriasis
And this funny man…
8 Million
Americans
Plaque Psoriasis
Most common
85-90%
Genetics
Alcohol
Cigarettes
MedicationSkin injury
Trauma
Infections
Stress
Triggers
What happens?
• Initial event: trauma, illness, etc
• Starts acute inflammatory process – but doesn’t stop there - genetics
• T cells get involved – cause release of cytokines – leads to chronic
inflammation
• Psoriatic plaques create new blood vessels – allows cytokines to travel
throughout body – causing inflammatory problems far beyond the skin
Comorbidities
and Psoriasis
Cardiovascular and metabolic disease
Cancer – lymphoma
Obesity
Ocular inflammation
IBD - UC/Crohns
Psoriatic Arthritis – 30%
Psychological – Depression/anxiety
Terminology
• BSA – Body Surface Area
• Rules of nine
• Palm – 1%
• IGA – Investigator’s Global
Assessment (studies)
• Induration, erythema, scale
• 0-4
• PASI – Psoriasis Area and Severity
Index (studies)
• Divide body into four sections
• Induration, erythema, scale
• % of area covered
• 0-4
• Absolute: 0-72
Psychological Impact
• NPF QOL study
• 5604 patients
• Embarrassed?
• Angry/frustrated?
• Helpless?
• Disfigured/unsightly?
• Self conscious?
88%
PSO impacts overall
emotional wellbeing
82%
PSO impacts ability to
enjoy life
7 Million
Americans
Treatments
• Topical corticosteroids/calcipotriene
• New: halobetasol and tazarotene lotion
• (Duobrii)
• MTX
• Biologics
• Only 36% with mod/severe psoriasis
• Goal of Treatment: NPF <1% BSA at 3
months
Lesson on names…
• - mab = monoclonal antibodies
• -ki (n) = interleukin
• The substem proceeding –mab: indicates from which animal the antibody was obtained
• Mouse: -omab
• Humanized: -zumab
• Human and mouse
• Human: -umab
Etanercept
Adalimumab
Certolizumab
pegol
Ustekinumab
Guselkumab
Ixekizumab
Secukinumab
*Brodalumab*
Apremilast
JAK
Inhibitors
Hidradenitis Suppurativa
Celebrities????
What is it?
Follicular disease in the areas of apocrine glands
Genetics, hormones, infections, smoking, obesity, irritants
Most commonly Staph aureus
Pathophysiology similar to acne – but chronically inflammatory
And…
Comorbidities• Obesity
• Metabolic syndrome
• Depression/anxiety
• Arthritis
• IBD
• PCOS
• CAD, anemia
Complications• Chronic pain
• Fistulae
• Lymphedema
• SSC
Treatments
• Antibacterial cleansers
• Weight reduction
• Smoking Cessation
• Lasers and surgery
• Antibiotics, IL steroids, spironolactone, finasteride, isotretinoin
Humira
(Adalimumab)
12 years of age and up
Mod/severe HS
Two 80 mg pens on day 1; One 80 mg pen on day 15; then 40 mg every two weeks starting on day 29
Atopic Dermatitis
And the list goes on…..
Eczema
Chronic contact dermatitis
7,450,560
Atopic
dermatitis
2,912,597*
Chronic
contact
unspecified
dermatitis
6,441,403*
Chronic
allergic
dermatitis
487,000*
Chronic
irritant
dermatitis
27,000*
Acute
allergic
dermatitis
1,790,000*
*Source: PDDA, patients diagnosed and treated.
Eczema: A Prevalent Condition
ATOPIC
DERMATITIS
Definition
Pruritic disease
01Usually starts in infancy
02Signs and symptoms
• Pruritus
• Excoriations
• Xerosis
• lichenification
03
LICHENIFICATION
CAUSES
‘AD’ Treatment
Avoid irritants/allergens/causative agents
Moisturize – to restore barrier
Topical steroids
Oral steroids/antibiotics
Dr. Aron’s Regimen
for AD
• Compounded product
• Betamethasone
• Mupirocin
• Vanicream
• Apply up to six times daily for first week, decreasing there after
Comorbidities
and AD?
Asthma
Seasonal allergies
• Cardiovascular disease
• Diabetes
• Obesity
• Anxiety/depression
• Autoimmune disorders
But what about:
The more
severe the AD
– the higher
the risk
Immune/
Inflammatory
Process
• PDE4 inhibitor
• PDE4 – phosphodiesterase 4 – enzyme involved in the production of inflammatory mediators in immune cells
• Only indication: atopic dermatitis
• EXPENSIVE
Eucrisa
• Monoclonal antibody
• 12 and older
• Elevated IgE
Dupixent
JAK Inhibitors
JAK Inhibitors
Topical and oral meds
01None currently approved
02Ruxolitinib – applied BID in study – 71.6% improvement at 4 weeks
• Eczema Area and Severity Index (EASI)
• Out performed TMC
03
Theme?
• Genetics
• Inflammation
• Acute inflammation starts process
• Genetics steps in
• Chronic inflammation results
• Systemic
Dietary Guidelines
• Hypocaloric diet and weight reduction in overweight/obese individuals
• Smaller portions rather than fad diets/surgery
• Healthy choices
• Mediterranean diet – PSO
• Paleo - HS
• Gluten free diet for patients who test positive for serologic markers of gluten sensitivity
• Oral Vit D supplement
Still Another Common
Denominator…
Quality of Life Tools
Do You Ask?